QA: Carisma Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2020_Carisma_Therapeutics_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 15.56275683926265, 'aggregate_val': 141065000, 'exp_sum': 8517000, 'exp_to_value': {'LiabilitiesCurrent': 8517000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 0}}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 54,447,000
1 IntangibleAssetsNetIncludingGoodwill 59,464,000
2 PropertyPlantAndEquipmentNet 238,000
3 remainder_Assets 216,000
4 LiabilitiesCurrent 8,517,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 132,548,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,098,037
9 ResearchAndDevelopmentExpense 24,939,541
10 remainder_Expenses 56,552,941
11 remainder_Revenues 0
12 remainder_NetIncome 933,952
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 114,365,000
1 Liabilities 141,065,000
2 Expenses 93,590,519
3 Revenues 0
4 StockholdersEquity -26,700,000
5 NetIncome -92,656,567
6 ComprehensiveNetIncome -92,656,567
7 BaseVar 174,977,236
8 EconomicCapitalRatiobeforeLimitedLiability -1.18
9 EconomicCapitalRatio 1.26

Edgar->Model Mapping

Feature Distribution

Change over Time